These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7786605)

  • 1. Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamide.
    Stekar J; Hilgard P; Klenner T
    Eur J Cancer; 1995; 31A(3):372-4. PubMed ID: 7786605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of epsilon-aminocaproic acid, cyclophosphamide and their combination on the growth of autochthonous sarcomas of mice induced by benzo(a)pyrene].
    Anikin IV; Tyndyk ML; Zabezhinskiĭ MA; Popovich IG; Anisimov VN; Pliss GB
    Vopr Onkol; 2014; 60(1):94-5. PubMed ID: 24772624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leucocyte nadir, a predictor of chemotherapy efficacy?
    Kvinnsland S
    Br J Cancer; 1999 Aug; 80(11):1681. PubMed ID: 10468282
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of sodium fluoroacetate on Ehrlich solid tumor and autochthonous sarcoma growth in mice].
    Anikin IV; Goncharov NV; Tyndyk ML; Voĭtenko NG; Pliss GB; Zabezhinskiĭ MA; Popovich IG; Anisimov VN
    Vopr Onkol; 2013; 59(6):777-80. PubMed ID: 24624791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Methylformamide (NSC 3051): a potential candidate for combination chemotherapy.
    Langdon SP; Hickman JA; Gescher A; Stevens MF; Chubb D; Vickers LM
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):745-52. PubMed ID: 4018116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Polyphenolic Composition BP-C3 on the Efficacy and Hematological Toxicity of Cyclophosphamide in the Chemotherapy of Mice Bearing Soft Tissue Sarcomas Induced by Benzo[a]pyrene.
    Panchenko AV; Fedoros EI; Pigarev SE; Maydin MA; Gubareva EA; Kireeva GS; Tyndyk ML; Kuznetsova AI; Nekhaeva TL; Danilova AB; Baldueva IA; Anisimov VN
    Integr Cancer Ther; 2019; 18():1534735419833778. PubMed ID: 30841763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of 5-mercapto-6-azauracil and cysteine on the toxicity of cyclophosphamide].
    Timar M; Vrejoiu G; Teodorescu M; Eneskcu L
    Farmakol Toksikol; 1968; 31(6):741-2. PubMed ID: 5756534
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumour and toxic effects on Wistar rats of two new platinum complexes.
    Charalabopoulos K; Karkabounas S; Ioachim E; Papalimneou V; Syrigos K; Evangelou A; Agnantis N; Hadjiliadis N
    Eur J Clin Invest; 2002 Feb; 32(2):129-33. PubMed ID: 11895460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
    Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
    Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.
    Poikonen P; Saarto T; Lundin J; Joensuu H; Blomqvist C
    Br J Cancer; 1999 Aug; 80(11):1763-6. PubMed ID: 10468293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the cytotoxicity of penicillamine in a rat osteogenic sarcoma.
    Cosolo W; Christophidis N; Drummer OH; Findlay DM
    Clin Exp Pharmacol Physiol; 1986 Oct; 13(10):737-43. PubMed ID: 3467882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506).
    Hilgard P; Stekar J; Voegeli R; Engel J; Schumacher W; Eibl H; Unger C; Berger MR
    Eur J Cancer Clin Oncol; 1988 Sep; 24(9):1457-61. PubMed ID: 3141197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of sodium fluoroacetate and metformin on the antitumor activity of cyclophosphamide on the autochthonous mice sarcoma model].
    Anikin IV; Goncharov NV; Tyndyk ML; Voĭshenko NG; Pliss GB; Zabezhinskiĭ MA; Popovich IG; Anisimov VN
    Vopr Onkol; 2014; 60(4):514-6. PubMed ID: 25552075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
    Nikolin VP; Kaledin VI; Baĭmak TIu; Galiamova MR; Popova NA; Voĭtsitskiĭ VE
    Vopr Onkol; 2002; 48(2):211-5. PubMed ID: 12227071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E but not St. John's wort mitigates leukopenia caused by cancer chemotherapy in rats.
    Branda RF; Powden C; Brooks EM; Yildirim Z; Naud SJ; McCormack JJ
    Transl Res; 2006 Dec; 148(6):315-24. PubMed ID: 17162253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylphosphocholines: a new class of membrane-active anticancer agents.
    Hilgard P; Klenner T; Stekar J; Unger C
    Cancer Chemother Pharmacol; 1993; 32(2):90-5. PubMed ID: 8485813
    [No Abstract]   [Full Text] [Related]  

  • 17. [A study of the antitumor effectiveness of endoxan when administered in various ways].
    Zaitseva LA; Syrkin AB
    Vopr Onkol; 1969; 15(11):99-101. PubMed ID: 5368849
    [No Abstract]   [Full Text] [Related]  

  • 18. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
    Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
    Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of synchronization induced by cyclophosphamide in a methylcholanthrene sarcoma with circadian proliferation to rational sequential chemotherapy.
    Focan C; Barbason H; Betz EH
    Biomedicine; 1975 Jun; 23(6):230-5. PubMed ID: 1240011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN; Papadopoulos NE; Chawla SP; Fenoglio C; Cooper S; Buescher ES; Frenck RW; Holian A
    J Clin Oncol; 1992 Aug; 10(8):1266-77. PubMed ID: 1634916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.